Omega Healthcare Investors (NYSE:OHI) Price Target Raised to $56.00

Omega Healthcare Investors (NYSE:OHI) had its price objective lifted by stock analysts at UBS Group from $52.00 to $56.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the real estate investment trust’s stock. UBS Group‘s target price points to a potential upside of 16.35% from the company’s previous close.

A number of other research firms have also commented on OHI. Raymond James Financial reaffirmed an “outperform” rating and set a $54.00 price objective on shares of Omega Healthcare Investors in a research note on Monday. Mizuho upped their target price on shares of Omega Healthcare Investors from $45.00 to $46.00 and gave the company a “neutral” rating in a report on Monday, August 31st. Cantor Fitzgerald raised their price target on shares of Omega Healthcare Investors from $52.00 to $56.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Wall Street Zen upgraded shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Saturday, October 17th. Finally, Wells Fargo & Company reduced their price objective on shares of Omega Healthcare Investors from $48.00 to $46.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. Seven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Omega Healthcare Investors currently has a consensus rating of “Hold” and an average price target of $50.27.

Omega Healthcare Investors Trading Down 1.2%

NYSE:OHI traded down $0.57 during trading hours on Wednesday, hitting $48.13. The company’s stock had a trading volume of 1,520,756 shares, compared to its average volume of 2,076,337. The stock has a market capitalization of $14.65 billion, a P/E ratio of 19.41, a price-to-earnings-growth ratio of 1.97 and a beta of 0.56. The stock has a fifty day moving average of $46.41 and a 200-day moving average of $46.73. Omega Healthcare Investors has a 52-week low of $42.18 and a 52-week high of $52.39.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Tuesday, November 3rd. The real estate investment trust reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.20). Omega Healthcare Investors had a return on equity of 13.66% and a net margin of 58.11%. The company had revenue of $340.55 million for the quarter, compared to analyst estimates of $269.16 million. During the same period in the previous year, the business posted $0.79 EPS. The firm’s revenue for the quarter was down 3.0% compared to the same quarter last year. On average, sell-side analysts forecast that Omega Healthcare Investors will post 3.12 earnings per share for the current year.

Institutional Investors Weigh In On Omega Healthcare Investors

A number of large investors have recently bought and sold shares of OHI. BlackRock Inc. acquired a new position in shares of Omega Healthcare Investors in the 2nd quarter valued at $1,838,155,000. Bank of New York Mellon Corp acquired a new position in Omega Healthcare Investors in the second quarter valued at about $275,230,000. Dimensional Fund Advisors LP boosted its position in Omega Healthcare Investors by 2.5% in the first quarter. Dimensional Fund Advisors LP now owns 4,423,120 shares of the real estate investment trust’s stock valued at $193,824,000 after buying an additional 108,736 shares in the last quarter. Bank of America Corp DE boosted its position in Omega Healthcare Investors by 3.6% in the first quarter. Bank of America Corp DE now owns 3,794,730 shares of the real estate investment trust’s stock valued at $166,285,000 after buying an additional 131,000 shares in the last quarter. Finally, Quantinno Capital Management LP grew its stake in Omega Healthcare Investors by 48.5% during the first quarter. Quantinno Capital Management LP now owns 2,125,931 shares of the real estate investment trust’s stock worth $93,158,000 after buying an additional 694,426 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT) focused on healthcare facilities, particularly skilled nursing and assisted living properties. The company invests in these facilities through real estate leases, loans and other financing arrangements. Its portfolio serves healthcare operators in the United States and the United Kingdom. Omega primarily leases properties to third-party operators, which manage the facilities and provide care to residents. Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega is led by President and Chief Executive Officer Taylor Pickett.